International coalition of researchers finds 6 new Sjögren's syndrome genes

Their work appears in the journal Nature Genetics.

Sjögren's syndrome is an autoimmune disease in which the immune system becomes confused and turns against the body's moisture-producing glands, damaging the ability to produce saliva or tears. Common symptoms include dry eyes and dry mouth, but the disease can also affect other organs and cause a variety of additional symptoms including severe fatigue, arthritis and memory problems.

The Sjögren's Syndrome Foundation estimates as many as 4 million Americans have the disease. Despite outnumbering patients with lupus, multiple sclerosis and other more commonly recognized autoimmune diseases, research into Sjögren's has been slow, said OMRF scientist Kathy Sivils, Ph.D.

“One problem has always been identifying true Sjögren's patients and collecting enough samples, partly because there's still disagreement on the criteria for the disease and clinical testing is not easy,” she said. “So much work goes into classifying patients that it makes building collections of samples more difficult.”

This research required Sjögren's researchers from around the world putting together about 2,000 patient samples, which were tested against more than 7,000 healthy controls.

The results were exactly what the researchers were hoping to see. In addition to the previously known HLA gene related to the disease, the group was able to identify six new Sjögren's genes and begin working to understand their functions.

“This is a first step,” said OMRF scientist Christopher Lessard, Ph.D., lead author of the paper. “Now that we've identified these genes, we can dig down and start to understand how these genetic variants alter normal functions of the immune system.”

So far, the international team of researchers led by Sivils, called the Sjögren's Genetics Network, or SGENE, has found these disease-related genes:

IRF5 and STAT4 which are “master regulators” that activate cells during an immune response

CXCR5 directs traffic for lymphocytes and may help explain why immune cells target moisture-producing glands.

TNIP1 is a binding partner with another autoimmune disease-related gene, TNFAIP3, which “cuts the brakes” on the immune system.

IL12A is one subunit of a protein that acts as a messenger between cells and modulates immune responses.

BLK is a B-cell gene which might account for increased numbers of antibodies.

Currently, the only treatment for Sjögren's syndrome is to target symptoms. Patients with chronic dry mouth use artificial saliva to chew and swallow. Dry eyes, which sometimes are difficult to open or blink, require artificial tears to function.

“I know it's a long ways off, but I hope these discoveries will open the door for researchers to find therapeutics that work at the genetic level to stop the disease,” she said.

Researchers from across the U.S. and from France, the United Kingdom, Germany, Colombia, Australia, Norway and Sweden contributed to the research. OMRF scientists involved in the paper include Darise Farris, Ph.D., Patrick Gaffney, M.D., Judith James, M.D., Ph.D., Courtney Montgomery, Ph.D., Robert Scofield, M.D., and Jonathan Wren, Ph.D.

Funding for the project was provided by grants No. P50 AR0608040 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases, 5R01 DE015223, 1R01 DE018209-02 and 5R01 DE018209 from the National Institute of Dental and Craniofacial Research, 5U19 AI082714 from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, and Sjögren's Syndrome Foundation.

Photos of Drs. Sivils and Lessard are available for download here: http://www.omrf.org/newsgallery/sjogrensgenes

About OMRF

OMRF is an independent, nonprofit biomedical research institute dedicated to understanding and developing more effective treatments for human diseases. Its scientists focus on such critical research areas as cancer, Sjögren's syndrome, lupus and cardiovascular disease.